Literature DB >> 30995302

Modulation of "Protective" Nicotine Perception and Use Profile by Flavorants: Preliminary Findings in E-cigarettes.

Elise E DeVito1, Kevin P Jensen1,2, Stephanie S O'Malley1, Ralitza Gueorguieva1,3, Suchitra Krishnan-Sarin1, Gerald Valentine1,2, Peter I Jatlow1,4, Mehmet Sofuoglu1,2.   

Abstract

INTRODUCTION: Characterizing flavors are widely available in e-cigarettes and motivate initiation and continued use. Flavors may enhance appeal and facilitate development of addiction to tobacco products through modulation of tobacco products' reinforcing or aversive actions. Palatable flavors (eg, fruit) may increase appeal through primary reinforcing properties. Menthol's cooling and anesthetic effects may increase appeal by counteracting nicotine's aversive effects. Genetics provide a method for modeling individual differences in sensitivity to nicotine's effects. A common polymorphism, rs16969968, encoded in the α5 nicotinic acetylcholine receptor subunit gene (CHRNA5), is a well-recognized marker for smoking risk and reduces sensitivity to nicotine aversiveness.
METHODS: This pilot study tested how flavors impacted e-cigarette appeal and self-administration. In a single testing day, cigarette smokers (N = 32; 94% menthol-smokers) self-administered e-cigarettes containing e-liquids differing in nicotine level (0 mg/mL, 24 mg/mL) and flavor (unflavored, menthol, fruit-flavored) within directed and ad libitum e-cigarette paradigms. Subjective drug effects, number of puffs, rs16969968 genotype, plasma nicotine, and menthol glucuronide levels were collected.
RESULTS: Menthol partially ameliorated nicotine aversiveness; fruit did not. In nicotine's absence, fruit flavor increased self-reported preference and ad libitum use relative to menthol-containing or unflavored e-liquids. Individuals with high-smoking-risk rs16969968 genotype (N = 7) reported greater craving alleviation following directed administration of nicotine-containing e-liquids, showed a trend rating nicotine-containing e-liquids as less harsh, and self-administered more nicotine during ad libitum compared to individuals with low-smoking-risk genotype (N = 23).
CONCLUSIONS: While menthol countered aversiveness of nicotine-containing e-liquids, fruit flavor increased appeal of nicotine-free e-liquids. These preliminary findings suggest menthol and fruit flavor increase e-cigarettes' appeal through distinct mechanisms. IMPLICATIONS: This study provides a detailed characterization of the effects of flavors (unflavored, menthol, fruit), nicotine (0 mg/mL, 24 mg/mL) and their interactions on the subjective drug effects and ad libitum self-administration of e-cigarettes. Genetics were used to assess these effects in higher-smoking-risk (diminished sensitivity to nicotine aversiveness) and lower-risk groups. Findings could inform impact of regulation of flavors or nicotine in e-cigarettes, and their impacts on vulnerable sub-populations.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 30995302     DOI: 10.1093/ntr/ntz057

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  16 in total

Review 1.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

Review 2.  History repeats itself: Role of characterizing flavors on nicotine use and abuse.

Authors:  Theresa Patten; Mariella De Biasi
Journal:  Neuropharmacology       Date:  2020-06-01       Impact factor: 5.250

3.  Sensory attributes of e-cigarette flavours and nicotine as mediators of interproduct differences in appeal among young adults.

Authors:  Adam Leventhal; Junhan Cho; Jessica Barrington-Trimis; Raina Pang; Sara Schiff; Matthew Kirkpatrick
Journal:  Tob Control       Date:  2019-12-18       Impact factor: 7.552

4.  Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers.

Authors:  Adam M Leventhal; Nicholas I Goldenson; Jessica L Barrington-Trimis; Raina D Pang; Matthew G Kirkpatrick
Journal:  Drug Alcohol Depend       Date:  2019-08-01       Impact factor: 4.492

5.  A Simple Computational Approach to Identify Potential Drugs for Multiple Sclerosis and Cognitive Disorders from Expert Curated Resources.

Authors:  Kalpana Raja; Archana Prabahar; Shyam Sundar Arputhanatham
Journal:  Methods Mol Biol       Date:  2022

6.  Flavor and Nicotine Effects on E-cigarette Appeal in Young Adults: Moderation by Reason for Vaping.

Authors:  Adam M Leventhal; Tyler B Mason; Sam N Cwalina; Lauren Whitted; Marissa Anderson; Carly Callahan
Journal:  Am J Health Behav       Date:  2020-09-01

7.  Menthol in electronic cigarettes: A contributor to respiratory disease?

Authors:  Vijayalekshmi Nair; Malcolm Tran; Rachel Z Behar; Song Zhai; Xinping Cui; Rattapol Phandthong; Yuhuan Wang; Songqin Pan; Wentai Luo; James F Pankow; David C Volz; Prue Talbot
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-17       Impact factor: 4.219

8.  E-cigarette device power moderates the effects of non-tobacco flavors and nicotine on product appeal in young adults.

Authors:  Adam M Leventhal; Tyler B Mason; Matthew G Kirkpatrick; Marissa K Anderson; Michael D Levine
Journal:  Addict Behav       Date:  2020-03-19       Impact factor: 3.913

9.  The effects of inhaled flavors on intravenous nicotine.

Authors:  R Ross MacLean; Ralitza Gueorguieva; Elise E DeVito; MacKenzie R Peltier; Suprit Parida; Mehmet Sofuoglu
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-28       Impact factor: 3.157

10.  Influence of menthol and green apple e-liquids containing different nicotine concentrations among youth e-cigarette users.

Authors:  Asti Jackson; Barry Green; Hanno C Erythropel; Grace Kong; Dana A Cavallo; Tore Eid; Ralitza Gueorguieva; Eugenia Buta; Stephanie S O'Malley; Suchitra Krishnan-Sarin
Journal:  Exp Clin Psychopharmacol       Date:  2020-04-16       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.